{"id":107489,"date":"2023-08-18T17:41:30","date_gmt":"2023-08-18T12:11:30","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=107489"},"modified":"2023-08-18T17:41:32","modified_gmt":"2023-08-18T12:11:32","slug":"ipo-update-concord-biotech-shares-surge-27-on-issue","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/","title":{"rendered":"IPO Update: Concord Biotech Shares Surge 27% on Issue"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3368718325\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Concord is among leading manufacturers of fermentation-based biopharmaceutical active pharmaceutical ingredients (API), focused on niche segments such as immunosuppressant, oncology, antifungal and antibacterial. <\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1217923657\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>The company, which has 23 API products, has three manufacturing facilities at Valthera, Dholka, and Limbasi, in Gujarat.<\/p><p>Shares of Concord Biotech ended with a premium of over 27% against the issue price of Rs 741 in its debut trade on Friday. The stock began the trade at Rs 900.05, registering a jump of 21.46% against the issue price on the BSE. <\/p><p>During the day, it zoomed 33.20% to Rs 987.05. Shares of the company ended at Rs 941.85, up 27.10%.<\/p><div class=\"trade-content_5\" id=\"trade-1159686692\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>At the NSE, it listed at Rs 900.05 and further rallied 33.29% to Rs 987.70. The stock ended at Rs 943.50, a gain of 27.32%. The company commanded a market valuation of Rs 9,853.28 crore. In traded volume terms, 15.45 lakh shares of the firm were traded on the BSE and over 2.42 crore shares on the NSE during the day.<\/p><p>The Initial Public Offer (IPO) of Concord Biotech was subscribed 24.86 times last week. The Rs 1,550.59 crore initial share-sale had a price range of Rs 705-741 a share. Rare Enterprises-backed Concord Biotech&#8217;s IPO was entirely an Offer For Sale (OFS).<\/p><div class=\"trade-after-content\" id=\"trade-4071314143\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Concord is among leading manufacturers of fermentation-based biopharmaceutical active pharmaceutical ingredients (API), focused on niche segments such as immunosuppressant, oncology, antifungal and antibacterial. The company, which has 23 API products, has three manufacturing facilities at Valthera, Dholka, and Limbasi, in Gujarat. Shares of Concord Biotech ended with a premium of over 27% against the issue [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":41220,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1696,31],"tags":[],"class_list":["post-107489","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-corporate-action","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IPO Update: Concord Biotech Shares Surge 27% on Issue - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Concord is among leading manufacturers of fermentation-based biopharmaceutical active pharmaceutical ingredients (API), focused on niche segments such as immunosuppressant, oncology, antifungal and antibacterial.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IPO Update: Concord Biotech Shares Surge 27% on Issue\" \/>\n<meta property=\"og:description\" content=\"Concord is among leading manufacturers of fermentation-based biopharmaceutical active pharmaceutical ingredients (API), focused on niche segments such as immunosuppressant, oncology, antifungal and antibacterial.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-18T12:11:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-18T12:11:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/IPO-12-Cover-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/\",\"url\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/\",\"name\":\"IPO Update: Concord Biotech Shares Surge 27% on Issue - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/IPO-12-Cover-Image.jpg\",\"datePublished\":\"2023-08-18T12:11:30+00:00\",\"dateModified\":\"2023-08-18T12:11:32+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Concord is among leading manufacturers of fermentation-based biopharmaceutical active pharmaceutical ingredients (API), focused on niche segments such as immunosuppressant, oncology, antifungal and antibacterial.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/IPO-12-Cover-Image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/IPO-12-Cover-Image.jpg\",\"width\":1280,\"height\":854,\"caption\":\"IPO 12 - Cover Image\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IPO Update: Concord Biotech Shares Surge 27% on Issue\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"IPO Update: Concord Biotech Shares Surge 27% on Issue - Trade Brains Features","description":"Concord is among leading manufacturers of fermentation-based biopharmaceutical active pharmaceutical ingredients (API), focused on niche segments such as immunosuppressant, oncology, antifungal and antibacterial.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/","og_locale":"en_US","og_type":"article","og_title":"IPO Update: Concord Biotech Shares Surge 27% on Issue","og_description":"Concord is among leading manufacturers of fermentation-based biopharmaceutical active pharmaceutical ingredients (API), focused on niche segments such as immunosuppressant, oncology, antifungal and antibacterial.","og_url":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-08-18T12:11:30+00:00","article_modified_time":"2023-08-18T12:11:32+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/IPO-12-Cover-Image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/","url":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/","name":"IPO Update: Concord Biotech Shares Surge 27% on Issue - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/IPO-12-Cover-Image.jpg","datePublished":"2023-08-18T12:11:30+00:00","dateModified":"2023-08-18T12:11:32+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Concord is among leading manufacturers of fermentation-based biopharmaceutical active pharmaceutical ingredients (API), focused on niche segments such as immunosuppressant, oncology, antifungal and antibacterial.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/IPO-12-Cover-Image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/IPO-12-Cover-Image.jpg","width":1280,"height":854,"caption":"IPO 12 - Cover Image"},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/ipo-update-concord-biotech-shares-surge-27-on-issue\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"IPO Update: Concord Biotech Shares Surge 27% on Issue"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/107489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=107489"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/107489\/revisions"}],"predecessor-version":[{"id":107506,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/107489\/revisions\/107506"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/41220"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=107489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=107489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=107489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}